Christy Radecic / AP

Medical device manufacturer Stryker has added Mary Brainerd to its board of directors. Brainerd, the retired CEO of HealthPartners, a $6 billion not-for-profit hospital and health insurance system in Minnesota, will get an annual $60,000 retainer fee and about $500,000 worth of stock options, according to a federal filing posted by Stryker.

The kicker: Stryker sold $17 million worth of medical devices to HealthPartners between January 2016 through May 2017.

Why it matters: Many health care executives — at both not-for-profit and publicly traded companies — hold cushy positions on the boards of other companies. That isn't problematic in a vacuum, but it could raise questions about conflicts of interest if executives' organizations do business with the companies where they hold board power.

Update: A HealthPartners spokesperson said the system uses "competitive bidding processes for major contracts, and these are complex, evidence-based decisions made by purchasing leadership, not the CEO."

More industry examples: Brainerd's appointment to Stryker's board isn't unique. Here are some other examples of current and former not-for-profit health care executives who sit on the boards of for-profit health care companies that could have business arrangements:

  • Lloyd Dean, CEO of Dignity Health: former board director at Navigant, a health care consulting firm. (More controversially, Dean has been a long-time board member at Wells Fargo.)
  • Kevin Lofton, CEO of Catholic Health Initiatives: board director at Gilead Sciences, a pharmaceutical company known for its high-priced HIV and hepatitis C medicines.
  • William Roper, CEO of the University of North Carolina Health Care: board director at dialysis chain DaVita and pharmacy benefit manager Express Scripts.
  • Martha Marsh, former CEO of Stanford Health Care: board director at medical device company Edwards Lifesciences, medical supplies provider Owens & Minor and health care staffing firm AMN Healthcare.
  • Nancy Schlichting, former CEO of Henry Ford Health System: board director at pharmacy chain Walgreens Boots Alliance.
  • John Forsyth, CEO of Wellmark: board director at medical supplies and drug company Baxter International.
  • Denis Cortese, former CEO of Mayo Clinic: board director at Cerner, a company that sells electronic health records and billing software to hospitals and doctors' practices. (Cerner lost its Mayo Clinic contract two years ago.)
  • Ellen Zane, former CEO of Tufts Medical Center: board director at medical device company Boston Scientific.
  • Kenneth Samet, CEO of MedStar Health: board director at Evolent Health, a technology and consulting company for hospitals and health plans.
  • Diane Holder, CEO of UPMC Health Plan: board director at Evolent Health.

Go deeper

Deadly Hurricane Zeta slams U.S. Gulf Coast

A satellite image of Hurricane Zeta. Photo: National Hurricane Center/NOAA

Hurricane Zeta has killed at least one person after a 55-year-old man was "electrocuted by a downed power line" in Louisiana as the storm caused widespread power outages Wednesday night, per AP.

What's happening: Zeta made landfall south of New Orleans as a Category 2 hurricane earlier Wednesday before weakening to Category 1. But it was still "battering southeastern Louisiana and southern Mississippi with life-threatening storm surge, high winds, and heavy rain" late Wednesday, per the National Hurricane Center.

Updated 32 mins ago - Politics & Policy

Coronavirus dashboard

Illustration: Sarah Grillo/Axios

  1. Politics: Biden ahead in Wisconsin, Michigan as cases surge in the Midwest.
  2. Health: Fauci says U.S. may not return to normal until 2022 — Trump's testing czar: Surge "is real" and not just caused by more tests Some coronavirus survivors have "autoantibodies."
  3. Business: Consumer confidence sinking Testing is a windfall.
  4. World: Europe faces "stronger and deadlier" wave France imposes lockdown Germany to close bars and restaurants for a month.
  5. Sports: Boston Marathon delayed MLB to investigate Dodgers player who joined celebration after positive COVID test.
59 mins ago - Health

Fauci says U.S. may not return to normal until 2022

Director of the National Institute of Allergy and Infectious Diseases, Anthony Fauci, testifies during a September Senate hearing on COVID-19 in Washington, D.C. Photo: Graeme Jennings/Pool/AFP via Getty Images

NIAID director Anthony Fauci told the Journal of the American Medical Association on Wednesday he doesn't expect a COVID-19 vaccine to be ready until January 2021 or later.

What he's saying: Fauci said during the interview that the U.S. was in a "bad position" after failing to keep case numbers down post-summer. "We should have been way down in baseline and daily cases and we’re not," he said.

Get Axios AM in your inbox

Catch up on coronavirus stories and special reports, curated by Mike Allen everyday

Please enter a valid email.

Subscription failed
Thank you for subscribing!